0001104659-19-072597.txt : 20191213 0001104659-19-072597.hdr.sgml : 20191213 20191213163154 ACCESSION NUMBER: 0001104659-19-072597 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20191213 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191213 DATE AS OF CHANGE: 20191213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIFAST INC CENTRAL INDEX KEY: 0000910329 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090] IRS NUMBER: 133714405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31573 FILM NUMBER: 191284962 BUSINESS ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 BUSINESS PHONE: 7327640619 MAIL ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHRITE INC DATE OF NAME CHANGE: 19951120 FORMER COMPANY: FORMER CONFORMED NAME: XX DATE OF NAME CHANGE: 19950619 FORMER COMPANY: FORMER CONFORMED NAME: 00 DATE OF NAME CHANGE: 19950619 8-K 1 tm1925174d1_8k.htm FORM 8-K
0000910329 false 0000910329 2019-12-12 2019-12-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): December 13, 2019

 

MEDIFAST, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other

jurisdiction of incorporation)

001-31573

(Commission

File Number)

13-3714405

(I.R.S. Employer

Identification No.)

     
100 International Drive, Baltimore, Maryland 21202
(Address of Principal Executive Offices) (Zip Code)
 
Registrant's telephone number, including area code: (410) 581-8042
 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, par value $0.001 per share MED New York Stock Exchange

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 1.01.Entry into a Material Definitive Agreement.

 

On December 13, 2019, Medifast, Inc. (the “Company”) entered into an amendment to the Rights Agreement (the “Rights Agreement”), dated as of November 21, 2019, between the Company and American Stock Transfer & Trust Company, LLC, as rights agent (the “Amendment”).

 

The Amendment amends the definition of “Acquiring Person” contained in Section 1(a) of the Rights Agreement to provide that, in addition to the other exemptions set forth therein, an Acquiring Person shall not include any Person who or which together with all Affiliates or Associates of such Person is the Beneficial Owner of less than 20% of the Common Stock then outstanding and who or which is entitled to file, and has in calendar year 2019 filed, prior to the date of the Amendment, a statement on Schedule 13G (or any comparable or successor report), reflecting Beneficial Ownership of more than 10% of the Common Shares outstanding at the time of such filing.

 

A copy of the Amendment has been filed as Exhibit 4.1 hereto and is incorporated herein by reference. The foregoing description is qualified in its entirety by reference to the attached Amendment. Capitalized terms used and not otherwise defined herein have the meanings ascribed to them in the Amendment.

 

Item 3.03.Material Modification to Rights of Security Holders.

 

The description of the Amendment set forth above under Item 1.01 “Entry Into a Material Definitive Agreement” is incorporated into this Item 3.03 by reference.

 

Item 9.01.Financial Statements and Exhibits.

 

(d)Exhibits.

 

4.1First Amendment to Rights Agreement, dated as of December 13, 2019, by and between Medifast, Inc. and American Stock Transfer & Trust Company, LLC.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  MEDIFAST, INC.
  (Registrant)
         
  By:  /s/ Jason L. Groves, Esq.
     Name:  Jason L. Groves
     Title:  Executive Vice President, General Counsel & Corporate Secretary

 

 

Date: December 13, 2019 

 
 EX-4.1 2 tm1925174d1_ex4-1.htm EXHIBIT 4.1

Exhibit 4.1

 

FIRST AMENDMENT TO

RIGHTS AGREEMENT

 

 

This FIRST AMENDMENT TO RIGHTS AGREEMENT (this “Amendment”) is entered into as of December 13, 2019, by and between MEDIFAST, INC., a Delaware corporation (the “Company”), and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, a New York limited liability trust company, as rights agent (the “Rights Agent”). All capitalized terms used herein and not otherwise defined herein shall have the meaning(s) ascribed to them in that certain Rights Agreement dated as of November 21, 2019, by and between the Company and the Rights Agent (the “Rights Agreement”).

 

RECITALS

 

WHEREAS, the Company and the Rights Agent are parties to the Rights Agreement; and

 

WHEREAS, pursuant to Section 27 of the Rights Agreement, the Company and the Rights Agent desire to amend the Rights Agreement as set forth in this Amendment.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the promises and the mutual agreements herein set forth, the parties hereto hereby agree as follows:

 

1.            Amendment of Section 1(a). Section 1 of the Rights Agreement is hereby amended by adding a new clause (a) as follows and renumbering the remainder of Section 1 accordingly:

 

“(a)            “13G Institutional Investor” shall have the meaning set forth in Section 1(b).”

 

2.            Amendment of definition of “Acquiring Person”. Section 1 is hereby amended by amending and restating existing clause (a) as a new clause (b) as follows:

 

 1 

 

 

“(b)            “Acquiring Person” shall mean any Person who or which, together with all Affiliates and Associates of such Person, shall be the Beneficial Owner of 10% or more of the Common Shares then outstanding, but shall not include (i) the Company, any Subsidiary of the Company, any employee benefit plan of the Company or any Subsidiary of the Company, or any entity holding Common Shares for or pursuant to the terms of any such plan or (ii) any Person who or which, together with all Affiliates or Associates of such Person, is the Beneficial Owner of less than 20% of the Common Shares then outstanding and who or which is entitled to file, and has in calendar year 2019 filed, prior to the date of the First Amendment to this Agreement, a statement on Schedule 13G (or any comparable or successor report) pursuant to Rule 13d-1(b)(1) of the General Rules and Regulations promulgated under the Exchange Act, as in effect on the date of this Agreement, reflecting Beneficial Ownership of more than 10% of the Common Shares outstanding at the time of such filing (a “13G Institutional Investor”); provided, however, that a Person who or which was a 13G Institutional Investor shall no longer be a 13G Institutional Investor from and after the time that it became subject to an obligation to file (regardless of the due date of such filing) a statement on Schedule 13D (or any comparable or successor report) pursuant to Rule 13d-1(a), Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g) of the General Rules and Regulations promulgated under the Exchange Act, as in effect on the date of this Agreement, with respect to the Common Shares that are Beneficially Owned by such Person, together with all Affiliates and Associates of such Person, and shall be deemed to be an Acquiring Person if it, together with all Affiliates and Associates of such Person, is the Beneficial Owner of 10% or more of the Common Shares then outstanding at any point from and after the time that it first became subject to an obligation to file (regardless of the due date of such filing) such statement on Schedule 13D; provided, however, that if at such time the Beneficial Ownership of Common Shares then outstanding of such Person, together with all Affiliates and Associates of such Person, is not less than 10%, then such Person shall have 30 days from such time to reduce the Beneficial Ownership of Common Shares of such Person, together with all Affiliates and Associates of such Person, to less than 10% of the Common Shares then outstanding before being deemed to be an Acquiring Person, but shall be deemed to be an Acquiring Person if after reducing its, together with all Affiliates and Associates of such Person, Beneficial Ownership of Common Shares then outstanding to less than 10% of the Common Shares then outstanding it, together with all Affiliates and Associates of such Person, subsequently becomes the Beneficial Owner of 10% or more of the Common Shares then outstanding or if, prior to reducing its, together with all Affiliates and Associates of such Person, Beneficial Ownership of the Common Shares then outstanding to less than 10%, it, together with all Affiliates and Associates of such Person, increases its Beneficial Ownership of Common Shares then outstanding (other than as a result of an acquisition of Common Shares by the Company) above the lowest Beneficial Ownership of Common Shares of such Person, together with all Affiliates and Associates of such Person, at any time during such 30 day period. Notwithstanding the foregoing, no Person who Beneficially Owns, as of the time of the public announcement of this Agreement, 10% (or 20% in the case of a Person who is a 13G Institutional Investor) or more of the Common Shares then outstanding shall become an Acquiring Person unless such Person shall, after the time of the public announcement of this Agreement, increase its Beneficial Ownership of the then outstanding Common Shares (other than as a result of an acquisition of Common Shares by the Company) to an amount equal to or greater than the greater of (x) 10% (or 20% in the case of a Person who is a 13G Institutional Investor) or (y) the sum of (i) the lowest Beneficial Ownership of such Person as a percentage of the outstanding Common Shares as of any date on or after the date of the public announcement of this Agreement plus (ii) 0.001%. Notwithstanding the foregoing, no Person shall become an “Acquiring Person” as the result of an acquisition of Common Shares by the Company which, by reducing the number of Common Shares outstanding, increases the proportionate number of Common Shares Beneficially Owned by such Person to 10% (or 20% in the case of a Person who is a 13G Institutional Investor) or more of the Common Shares then outstanding; provided, however, that, if a Person shall become the Beneficial Owner of 10% (or 20% in the case of a Person who is a 13G Institutional Investor) or more of the Common Shares then outstanding by reason of share purchases by the Company and shall, after such share purchases by the Company, become the Beneficial Owner of any additional Common Shares (other than solely pursuant to a pro rata dividend or distribution by the Company to all holders of Common Shares), then such Person shall be deemed to be an “Acquiring Person.” Notwithstanding the foregoing, if the Board of Directors of the Company determines in good faith that a Person who would otherwise be an “Acquiring Person,” as defined pursuant to the foregoing provisions of this paragraph (a), has become such inadvertently, and such Person divests as promptly as practicable a sufficient number of Common Shares so that such Person would no longer be an “Acquiring Person,” as defined pursuant to the foregoing provisions of this paragraph (a), then such Person shall not be deemed to be an “Acquiring Person” for any purposes of this Agreement. Notwithstanding the foregoing, if a bona fide swaps dealer who would otherwise be an “Acquiring Person” has become so as a result of its actions in the ordinary course of its business that the Board of Directors of the Company determines, in its sole discretion, were taken without the intent or effect of evading or assisting any other Person to evade the purposes and intent of this Agreement, or otherwise seeking to control or influence the management or policies of the Company, then, and unless and until the Board of Directors shall otherwise determine, such Person shall not be deemed to be an “Acquiring Person” for any purposes of this Agreement.”

 

 2 

 

 

3.             Amendment of Exhibit C (Summary of Rights To Purchase Preferred Shares). Exhibit C to the Rights Agreement is hereby amended as follows:

 

(a) The third paragraph is hereby amended and restated in its entirety to be read as follows:

 

“In general terms, the Rights Agreement works by imposing a significant penalty upon any person or group which acquires 10% (or 20% in the case of certain institutional investors who report their holdings on Schedule 13G) or more of the outstanding Common Stock without the approval of our Board.”

 

(b) The section titled “Exercisability” is hereby amended and restated in its entirety to read as follows:

 

“Exercisability. The Rights will not be exercisable until 10 days after the public announcement that a person or group has become an “Acquiring Person” by obtaining beneficial ownership of 10% (or 20% in the case of certain institutional investors who report their holdings on Schedule 13G) or more of our outstanding Common Stock.”

 

4.            Agreement as Amended. The term “Agreement” or “Rights Agreement” as used in the Rights Agreement shall be deemed to refer to the Rights Agreement as amended. Except as set forth herein, the Rights Agreement shall remain in full force and effect and otherwise shall be unaffected hereby, and each of the Company and the Rights Agent shall continue to be subject to its terms and conditions.

 

5.            Severability. If any term, provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired or invalidated.

 

6.            Governing Law. This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such state applicable to contracts to be made and performed entirely within such state.

 

 3 

 

 

7.            Counterparts. This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signature to this Amendment transmitted electronically shall have the same authority, effect, and enforceability as an original signature.

 

[Signature Page Follows]

 4 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed, as of the day and year first above written.

 

 

 MEDIFAST, INC.
  
  
By:/s/ Daniel Chard
  Name: Daniel Chard
  Title: Chief Executive Officer

 

 

 AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC
  
  
By:/s/ Michael A. Nespoli
  Name: Michael A. Nespoli
  Title: Executive Director

 

 5 

 

 EX-101.SCH 3 med-20191213.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 med-20191213_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 med-20191213_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE JSON 6 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm1925174d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "tm1925174d1_8k.htm" ] }, "labelLink": { "local": [ "med-20191213_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "med-20191213_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "med-20191213.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "med", "nsuri": "http://medifast1.com/20191213", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm1925174d1_8k.htm", "contextRef": "From2019-12-12to2019-12-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://medifast1.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm1925174d1_8k.htm", "contextRef": "From2019-12-12to2019-12-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r9" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://medifast1.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r11": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r12": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r13": { "Name": "Forms 10-K, 20-F, 40-F", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-1" }, "r14": { "Name": "Forms 20-F, 40-F", "Number": "249", "Publisher": "SEC", "Section": "220 and 240", "Subsection": "f" }, "r15": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r18": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" } }, "version": "2.1" } XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 tm1925174d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000910329 2019-12-12 2019-12-13 iso4217:USD shares iso4217:USD shares 0000910329 false 8-K 2019-12-13 MEDIFAST, INC. DE 001-31573 13-3714405 100 International Drive Baltimore MD 21202 410 581-8042 Common Stock, par value $0.001 per share MED NYSE false false false false false ZIP 10 0001104659-19-072597-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-19-072597-xbrl.zip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end EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 1 97 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://medifast1.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm1925174d1_8k.htm med-20191213.xsd med-20191213_lab.xml med-20191213_pre.xml tm1925174d1_ex4-1.htm http://xbrl.sec.gov/dei/2019-01-31 true false XML 13 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Cover
Dec. 13, 2019
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 13, 2019
Entity File Number 001-31573
Entity Registrant Name MEDIFAST, INC.
Entity Central Index Key 0000910329
Entity Tax Identification Number 13-3714405
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 100 International Drive
Entity Address, City or Town Baltimore
Entity Address, State or Province MD
Entity Address, Postal Zip Code 21202
City Area Code 410
Local Phone Number 581-8042
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol MED
Security Exchange Name NYSE
Entity Emerging Growth Company false

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; }